about
Erectile dysfunction after radiotherapy for prostate cancer: a model assessing the conflicting literature on dose-volume effects.Comparison between the ICRU rectal point and modern volumetric parameters in brachytherapy for locally advanced cervical cancer.Value of mammography and breast ultrasound in male patients with nipple discharge.Implementation of the global risk analysis in pulsed-dose rate brachytherapy: methods and results.[Hypofractionated radiotherapy for breast cancer in elderly patients: current evidence and future perspectives]Radiotherapy in rectal cancer: development, adequacy and radiotherapy utilisation rate. A comparative analysis with the most frequent tumour sitesIntrafractional organs movement in three-dimensional image-guided adaptive pulsed-dose-rate cervical cancer brachytherapy: assessment and dosimetric impactIndividualizing adjuvant radiotherapy in patients with breast cancer: let's not get ahead of ourselvesComparison of 3D conformal radiation therapy and intensity-modulated radiation therapy in patients with endometrial cancer: efficacy, safety and prognostic analysisPooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC)Outcomes of vaginal squamous cell carcinoma of patients treated with radiation therapy: a series of 37 patients from a single expert centerLate toxicity for prostate cancer patients treated with hypofractionated helical tomotherapyPartial versus whole breast irradiation: Side effects, patient satisfaction and costsOverexpression of Canonical Prefoldin Associates with the Risk of Mortality and Metastasis in Non-Small Cell Lung Cancer
P50
Q38115726-B724E549-6BA5-4E4A-A461-EBBDC1F5419CQ44103500-A60B61C2-56F4-4713-B25A-096713E87D30Q45329924-227BE6D0-8187-4C44-A788-FEDA880720A2Q53335455-CCBAEC9F-0BA7-4E69-ADEF-E12D5F8D2D01Q57105162-2D994EAA-0500-43C9-9E63-3A9097AABE66Q83419632-A67BABBD-8937-4553-BA78-02063EBACA41Q86444566-066E8A33-13F5-45AE-8C33-C4EDCB49106AQ87653934-D4ACF622-27E5-43F9-94F8-55C2C0BFA6C2Q90264140-38030FCD-86E0-406F-AC90-6E2109D4582DQ90416142-4DD8B0E7-8DEF-4F38-8485-179285A3C182Q92233270-02E3AB7F-3BBE-4A9C-8089-BD1CC8D3D4CCQ92708918-66468BC9-8ADC-413C-AFA0-0E50F53D2C5AQ92726390-9D10052A-5725-4A22-B54E-24245BF2DDDDQ94448722-F1DCCF3F-60C0-4804-B949-FDB7FD717C42
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Eleonor Rivin del Campo
@en
Eleonor Rivin del Campo
@nl
type
label
Eleonor Rivin del Campo
@en
Eleonor Rivin del Campo
@nl
prefLabel
Eleonor Rivin del Campo
@en
Eleonor Rivin del Campo
@nl
P31
P496
0000-0003-3319-7287